Abstract:Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder characterized by motor, cognitive and psychiatric manifestations. Since the mutation responsible for the disease was identified as an unstable expansion of CAG repeats in the gene encoding the huntingtin protein in 1993, numerous mouse models of HD have been generated to study disease pathogenesis and evaluate potential therapeutic approaches. Of these, knock-in models best mimic the human condition from a genetic perspective since they express the mutation in the appropriate genetic and protein context. Behaviorally, however, while some abnormal phenotypes have been detected in knock-in mouse models, a model with an earlier and more robust phenotype than the existing models is required. We describe here for the first time a new mouse line, the zQ175 knock-in mouse, derived from a spontaneous expansion of the CAG copy number in our CAG 140 knock-in colony [1]. Given the inverse relationship typically observed between age of HD onset and length of CAG repeat, since this new mouse line carries a significantly higher CAG repeat length it was expected to be more significantly impaired than the parent line. Using a battery of behavioral tests we evaluated both heterozygous and homozygous zQ175 mice. Homozygous mice showed motor and grip strength abnormalities with an early onset (8 and 4 weeks of age, respectively), which were followed by deficits in rotarod and climbing activity at 30 weeks of age and by cognitive deficits at around 1 year of age. Of particular interest for translational work, we also found clear behavioral deficits in heterozygous mice from around 4.5 months of age, especially in the dark phase of the diurnal cycle. Decreased body weight was observed in both heterozygotes and homozygotes, along with significantly reduced survival in the homozygotes. In addition, we detected an early and significant decrease of striatal gene markers from 12 weeks of age. These data suggest that the zQ175 knock-in line could be a suitable model for the evaluation of therapeutic approaches and early events in the pathogenesis of HD.

A Huntingtin Knockin Pig Model Recapitulates Features of Selective Neurodegeneration in Huntington's Disease

Expression of Huntington's Disease Protein Results in Apoptotic Neurons in the Brains of Cloned Transgenic Pigs

Cas9-mediated Replacement of Expanded CAG Repeats in a Pig Model of Huntington’s Disease

Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington's disease

Aberrant Splicing of Mutant Huntingtin in Huntington's Disease Knock-in Pigs.

Lack of Association of Somatic CAG Repeat Expansion with Striatal Neurodegeneration in HD Knock-in Animal Models

Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy.

Transgenic Animal Models for Study of the Pathogenesis of Huntington&rsquo;s Disease and Therapy

Comparing HD Knockin Pigs and Mice Reveals the Pathological Role of IL-17

Loss of Hap1 Selectively Promotes Striatal Degeneration in Huntington Disease Mice

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175

Neuropathology of Transgenic HD Animal Models

Accumulation of N-terminal Mutant Huntingtin in Mouse and Monkey Models Implicated As a Pathogenic Mechanism in Huntington's Disease

A Novel and Accurate Full-Length HTT Mouse Model for Huntington’s Disease

Hunting out the repeat expansion in Huntington's pigs

Towards a transgenic model of Huntington|[rsquo]|s disease in a non-human primate

Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer's Disease

Species-dependent Neuropathology in Transgenic SOD1 Pigs.

N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy.

Large Animal Models of Huntington's Disease.

Hemizygous Minipigs Produced by Random Gene Insertion and Handmade Cloning Express the Alzheimer'S Disease-Causing Dominant Mutation Appsw